ANOTHER FIN-FSA RELEASE IN THE MATTER AGAINST DR DANKO KONCAR

Summary by AI ^BETAClose X

Afarak Group SE (LSE: AFRK, NASDAQ: AFAGR) announced on 6 November 2025 that the Financial Supervisory Authority (FIN-FSA) has published information regarding Dr. Danko Koncar. Although the company explicitly stated this is not a direct company matter, Afarak was requested by FIN-FSA to inform its shareholders accordingly. This disclosure, despite being external to the company's immediate operations, could still be perceived by investors as having an indirect association or potential reputational implications, warranting careful consideration of its impact on the stock share price.

Disclaimer*

10:15 London, 12:15 Helsinki, 6 November 2025 - Afarak Group SE ("Afarak" or "the Company") (LSE: AFRK, NASDAQ: AFAGR)

ANOTHER FIN-FSA RELEASE IN THE MATTER AGAINST DR DANKO KONCAR

Stock Exchange Release

On 6 November 2025, the Financial Supervisory Authority (FIN-FSA) has published attached information. Although this is not a company matter, Afarak was requested by Fin-FSA to inform its shareholders accordingly.

Helsinki, November 6, 2025

AFARAK GROUP SE

Board of Directors

For additional information, please contact:

Afarak Group SE

Guy Konsbruck, CEO, +356 2122 1566, guy.konsbruck@afarak.com

Financial reports and other investor information are available on the Company's website: www.afarak.com.

Afarak Group is a specialist alloy producer focused on delivering sustainable growth with a Speciality Alloys business in southern Europe and a FerroAlloys business in South Africa. The Company is listed on NASDAQ Helsinki (AFAGR) and the Main Market of the London Stock Exchange (AFRK).

Distribution:
NASDAQ Helsinki
London Stock Exchange
Main media

www.afarak.com

Attachments